Taysha Gene Therapies
Price & Volume
Stats
See more52W Range | $2.71-$7.30 |
Market Cap | $1.9B |
Shares Short | 46M |
Financials
See moreRevenue (12 Mos) | $5.4M |
Revenue Growth (YoY) | 171.3% |
Gross Profit (12 Mos) | $5.4M |
Diluted EPS | -$0.41 |
News
See moreYahoo Finance • 6 days ago
Here are the major earnings before the open Wednesday
Yahoo Finance • 11 days ago
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 15 days ago
Taysha Gene Therapies and Catalent Expand Strategic Partnership to Include Future Commercial Manufacturing Support of TSHA-102 Gene Therapy for Rett Syndrome
Yahoo Finance • last month
Taysha Gene Therapies (TSHA) is One of The Most Affordable Biotech Names to Invest In
About
CEO | Mr. Sean P. Nolan |
CFO | Mr. Kamran Alam CPA, M.B.A. |
Address | 3000 Pegasus Park Drive, Dallas, TX, United States, 75247 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 99 |